Björn Reinius group

The Reinius laboratory's research is focused on revealing principal features of gene regulation, and in particular the regulation of active and inactive chromatin states. A main topic in the lab is X-chromosome inactivation.

Research focus: X-chromosome inactivation

Our research is focused on revealing principal features of gene regulation, and in particular the regulation of active and inactive chromatin states. A main topic in the lab is X-chromosome inactivation.

Female cells contain two X chromosomes while male cells contain only one, and to balance the X-gene dose in female cells one X copy is kept transcriptionally silenced by the process of X-chromosome inactivation. This is achieved by remarkable remodeling of the inactive X chromosome, which drastically changes its chromatin structure, methylation patterns, and three-dimensional conformation – ultimately suppressing the expression of most of its genes.

By characterizing the epigenetic framework of X-chromosome inactivation, we reveal important properties of gene regulation. During the last years Reinius and colleagues pioneered the use of single-cell RNA-seq in the study of X-inactivation (Science 2014, Cell 2016, Nature Genetics 2016 among other publications).

Currently the Reinius lab is working to determine the X-inactive landscape across a wide range of in vivo tissues and cell types. This is accomplished by a comprehensive synthesis of newly developed concepts and techniques, including single-cell RNA-sequencing, chromatin accessibility and modification assays, mouse genetics and transgenics, and recently advanced computational methods for the analysis of allele-specific gene expression.

Knowledge gained form this research is of broad biological significance, and may reveal gene-regulatory features underlying variable expressivity and incomplete penetrance of X-linked traits and genetic disorders.

Advancing RNA/DNA sequencing technology: High-throughput sequencing is key in our work, and is increasingly utilized in Medicine. We are working to invent and improve methods for RNA and DNA sequencing – tailoring the protocols to maximize the information yield in the context of specific experiments.

Do you want to be part of our research group?

Highly motivated students and postdoc are always welcome! If you want to apply for a grant together, or if you already carry your own grant and wish to come to the lab please contact us at bjorn.reinius@ki.se.

Research environment

Photo: Martin Stenmark

The Reinius laboratory is part of the Division of Biomaterials at Karolinska Institutet's Department for Medical Biochemistry and Biophysics. It's physically located in the Biomedicum building, a modern, purpose-built facility for experimental medical research. It hosts research groups with diverse backgrounds, forming a unique cluster with expertise in cellular and molecular biology, high-content RNA/DNA sequencing, epigenetics, bioinformatics, high-resolution imaging and novel DNA-based detection and imaging techniques, and many other subjects.

News

  • July 4, 2018. The lab is investing in a tailored computer cluster for in-house processing of sequencing data. Exciting times!
  • July 2, 2018. The lab is stacking up on high-end laboratory equipment.
  • June 25, 2018. The lab welcomes postdoctoral fellow Christos Coucoravas!

Publications

Selected publications

Funding

  • Ragnar Söderberg Fellowship in Medicine
  • The Swedish Research Council Starting Grant
  • Åke Wiberg’s Foundation
  • KI Faculty Funded Career Position (Foass)

Members and contact

Group leader

All members of the group

Visiting address

Karolinska Institute, Medical Biochemistry and Biophysics, Solnavägen 9, Quarter 9b, floor 9, Solna, 171 65, Sweden

Postal address

Karolinska Institute, Medical Biochemistry and Biophysics, Björn Reinius, Stockholm, 17177, Sweden

Delivery address

Tomtebodavägen 16, 9b, 171 77 Stockholm, Sweden

Keywords:
Bioinformatics and Systems Biology (methods development, see 10203) Cell and Molecular Biology Developmental Biology
BR
Content reviewer:
22-03-2024